Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...
Hospitalizations and general "syndromic" cases were at 10+ statewide for the week. The number of reported COVID cases ...
Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...
The Department of Health Services has awarded $590 million to Moderna to speed up the development of flu vaccines, including ...
Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...
Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and considered life-saving.
RNA vaccines are composed of the nucleic acid RNA, which encode antigen genes of an infectious agent. When administered to host cells, the RNA is translated into protein antigens that elicit ...